[1]
David B Oshevire, “In-silico investigation of curcumin drug-likeness, gene-targets and prognostic relevance of the targets in panels of human cancer cohorts”, GSC Biol. Pharm. Sci., vol. 14, no. 1, pp. 037–047, Jan. 2021.